On May 12, 2014, the CFIDS Association submitted a thorough review of the FDA Draft Guidance for Industry concerning ME/CFS. Read our feedback on the document and learn more…
FDA Webinar, Reviewing Draft Guidance for Industry CFS/ME, Held April 23rd
On Wednesday, April 23, 2014 FDA held a webinar to discuss the draft Guidance for Industry CFS/ME: Developing Drug Products for Treatment. We were on the webinar and are happy to provide a summary of what was discussed as well as next steps in the process…
FDA Releases New Draft Guidance for Industry “CFS/ME: Developing Drug Products for Treatment”
FDA Releases New Draft Guidance for Industry “CFS/ME: Developing Drug Products for Treatment” in order to assist sponsors in the development of drug products for the treatment of CFS/ME.
Hope on the Hill – ME/CFS in Washington DC
Hope on the Hill – ME/CFS in Washington DC: Our perspective on the federal government and why we continue our work.
FDA: The Voice of the Patient
On October 16 from 1:30 PM – 3:00 PM EST, FDA will hold a teleconference that is open to the public. Your voice is important in the dialogue.